Boldyreff B, Mietens U, Issinger O G
Biokemisk Institut, Odense Universitet, Denmark.
FEBS Lett. 1996 Jan 29;379(2):153-6. doi: 10.1016/0014-5793(95)01497-7.
Protein kinase CK2 has been shown to be elevated in all so far investigated solid tumors and its catalytic subunit has been shown to serve as an oncogene product. CK2 is a heterotetrameric serine-threonine kinase composed of two catalytic (alpha and/or alpha') and two regulatory beta-subunits. Using the two-hybrid system we could show that the alpha- or alpha'-subunits of CK2 can interact with the beta-subunits of CK2, but not with other alpha- or alpha'-subunits. By comparison, the beta-subunit of CK2 can interact with another beta-subunit. Important amino acids for successful dimerization of the beta-subunit were localized between amino acid residues 156 and 165. Furthermore, we identified residues between amino acid 170 and 180 which antagonize the dimerization.
蛋白激酶CK2在迄今所研究的所有实体瘤中均呈升高状态,并且其催化亚基已被证明可作为一种癌基因产物。CK2是一种由两个催化亚基(α和/或α')和两个调节性β亚基组成的异源四聚体丝氨酸 - 苏氨酸激酶。利用双杂交系统,我们能够证明CK2的α或α'亚基可与CK2的β亚基相互作用,但不能与其他α或α'亚基相互作用。相比之下,CK2的β亚基可与另一个β亚基相互作用。β亚基成功二聚化的重要氨基酸定位在氨基酸残基156和165之间。此外,我们鉴定出在氨基酸170和180之间的残基可拮抗二聚化。